LEVELS OF MINIMAL RESIDUAL DISEASE IN CHRONIC MYELOGENOUS LEUKEMIA (CML) PATIENTS IN COMPLETE CYTOGENETIC REMISSION AFTER INTERFERON-ALPHA-THERAPY CORRELATE WITH RISK OF RELAPSE
A. Hochhaus et al., LEVELS OF MINIMAL RESIDUAL DISEASE IN CHRONIC MYELOGENOUS LEUKEMIA (CML) PATIENTS IN COMPLETE CYTOGENETIC REMISSION AFTER INTERFERON-ALPHA-THERAPY CORRELATE WITH RISK OF RELAPSE, Experimental hematology, 24(9), 1996, pp. 579-579